Flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: A comparison of different flavonoids in activating estrogenic effect and in preventing β-amyloid-induced cell death

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 6, 2007, Pages 2438-2445

  Zhu, Judy T T ^a   Choi, Roy C Y ^a   Chu, Glanice K Y ^a   Cheung, Anna W H ^a   Gao, Qiu T ^a   Li, Jun ^a   Jiang, Zhi Y ^a   Dong, Tina T X ^a   Tsim, Karl W K ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

amyloid; Alzheimer's disease; Estrogen; Flavonoids; Neuroprotection

Indexed keywords

AMYLOID BETA PROTEIN; ESTROGEN; FLAVONOID; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; BREAST TUMOR; CELL DEATH; CELL STRAIN; COMPARATIVE STUDY; DNA RESPONSIVE ELEMENT; DRUG EFFECT; GENETICS; HUMAN; RAT; TUMOR CELL LINE;

AMYLOID BETA-PROTEIN; ANIMALS; BREAST NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; ESTROGENS; FLAVONOIDS; HUMANS; NEUROPROTECTIVE AGENTS; PC12 CELLS; RATS; REACTIVE OXYGEN SPECIES; RESPONSE ELEMENTS;

SCUTELLARIA;

EID: 34147181810     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf063299z     Document Type: Article

References (34)

1. Hall, J. M.; McDonnell, D. P. Coregulators in nuclear estrogen receptor action: From concept to therapeutic targeting. Mol. Interventions 2005, 5, 343-357.
2. Amantea, D.; Russo, R.; Bagetta, G.; Corasaniti, M. T. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol. Res. 2005, 52, 119-132.
3. Glazier, M. G.; Bowman, M. A. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch. Intern. Med. 2001, 161, 1161-1172.
4. Brinton, L. A.; Brogan, D. R.; Coates, R. J.; Swanson, C. A.; Potischman, N.; Stanford, J. L. Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy. Menopause 1998, 15, 145-151.
5. Henderson, V. W.; Paganini-Hill, A.; Miller, B. L.; Elble, R. J.; Reyes, P. F.; Shoupe, D.; McCleary, C. A.; Klein, R. A.; Hake, A. M.; Farlow, M. R. Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial. Neurology 2000, 54, 295-301.
6. Green, P. S.; Gridley, K. E.; Simpkins, J. W. Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 1996, 218, 165-168.
7. Goodenough, S.; Schafer, M.; Behl, C. Estrogen-induced cell signaling in a cellular model of Alzheimer's disease. J. Steroid Biochem. Mol. Biol. 2003, 84, 301-305.
8. Claassen, H.; Schunke, M.; Kurz, B. Estradiol protects cultured articular chondrocytes from oxygen-radical-induced damage. Cell Tissue Res. 2005, 319, 439-445.
9. Norbury, R.; Cutter, W. J.; Compton, J.; Robertson, D. M.; Craig, M.; Whitehead, M.; Murphy, D. G. The neuroprotective effects of estrogen on the aging brain. Exp. Gerontol. 2003, 38, 109-117.
10. Zhu, X.; Raina, A. K.; Lee, H. G.; Casadesus, G.; Smith, M. A.; Perry, G. Oxidative stress signalling in Alzheimer's disease. Brain Res. 2004, 1000, 32-39.
11. Irie, K.; Murakami, K.; Masuda, Y.; Morimoto, A.; Ohigashi, H.; Ohashi, R.; Takegoshi, K.; Nagao, M.; Shimizu, T.; Shirasawa, T. Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: Implications for the pathogenesis of Alzheimer's disease. J. Biosci. Bioeng. 2005, 437-447.
12. Tanzi, R. E.; Bertram, L. Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective. Cell 2005, 120, 545-555.
13. Miksicek, R. J. Commonly occurring plant flavonoids have estrogenic activity. Mol. Pharmacol. 1993, 44, 37-43.
14. Murkies, A. L.; Wilcox, G.; Davis, S. R. Clinical review 92: Phytoestrogens. J. Clin. Endocrinol. Metab. 1998, 83, 297-303.
15. Wang, C. N.; Chi, C. W.; Lin, Y. L.; Chen, C. F.; Shiao, Y. J. The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J. Biol. Chem. 2001, 276, 5287-5295.
16. Kim, H.; Park, B. S.; Lee, K. G.; Choi, C. Y.; Jang, S. S.; Kim, Y. H.; Lee, S. E. Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J. Agric. Food Chem. 2005, 53, 8537-8541.
17. Fujimoto, N.; Honda, H.; Kitamura, S. Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors alpha and beta. J. Steroid Biochem. Mol. Biol. 2004, 88, 53-59.
18. Hong, H.; Liu, G. Q. Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. Life Sci. 2004, 74, 2959-2973.
19. Yang, F.; Lim, G. P.; Begum, A. N.; Ubeda, O. J.; Simmons, M. R.; Ambegaokar, S. S.; Chen, P. P.; Kayed, R.; Glabe, C. G.; Frautschy, S. A.; Cole, G. M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005, 280, 5892-5901.
20. Hasegawa, K.; Yamaguchi, I.; Omata, S.; Gejyo, F.; Naiki, H. Interaction between A β (1-42) and A β (1-40) in Alzheimer's β-amyloid fibril formation in vitro. Biochemistry 1999, 38, 15514-15521.
21. Li, S. P.; Zhao, K. J.; Ji, Z. N.; Song, Z. H.; Dong, T. T.; Lo, C. K.; Cheung, J. K.; Zhu, S. Q.; Tsim, K. W. A polysaccharide isolated from Cordyceps sinensis, a traditional Chinese medicine, protects PC12 cells against hydrogen peroxide-induced injury. Life Sci. 2003, 73, 2503-2513.
22. Norbury, R.; Cutter, W. J.; Compton, J.; Robertson, D. M.; Craig, M.; Whitehead, M.; Murphy, D. G. The neuroprotective effects of estrogen on the aging brain. Exp. Gerontol. 2003, 38, 109-117.
23. Dixon-Shanies, D.; Shaikh, N. Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Oncol. Rep. 1999, 6, 1383-1387.
24. Zhao, L.; Chen, Q.; Diaz, Brinton, R. Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons. Exp. Biol. Med. (Maywood) 2002, 227, 509-519.
25. Merot, Y.; Ferriere, F.; Debroas, E.; Flouriot, G.; Duval, D.; Saligaut, C. Estrogen receptor alpha mediates neuronal differentiation and neuroprotection in PC12 cells: critical role of the A/B domain of the receptor. J. Mol. Endocrinol. 2005, 35, 257-267.
26. Linford, N.; Wade, C.; Dorsa, D. The rapid effects of estrogen are implicated in estrogen-mediated neuroprotection. J. Neurocytol. 2000, 29, 367-374.
27. Bryant, D. N.; Bosch, M. A.; Ronnekleiv, O. K.; Dorsa, D. M. 17-Beta estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain. Neuroscience 2005, 133, 343-352.
28. Singer, C. A.; Figueroa-Masot, X. A.; Batchelor, R. H.; Dorsa, D. M. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 1999, 19, 2455-2463.
29. Singh, M. Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex. Endocrine 2001, 14, 407-415.
30. Simoncini, T.; Fornari, L.; Mannella, P.; Varone, G.; Caruso, A.; Liao, J. K.; Genazzani, A. R. Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase. Steroids 2002, 67, 935-939.
31. Howes, M. J.; Perry, N. S.; Houghton, P. J. Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother. Res. 2003, 17, 1-18.
32. Lebeau, A.; Esclaire, F.; Rostene, W.; Pelaprat, D. Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity. NeuroReport 2001, 12, 2199-2202.
33. Shang, Y. Z.; Miao, H.; Cheng, J. J.; Qi, J. M. Effects of amelioration of total flavonoids from stems and leaves of Scutellaria baicalensis Georgi on cognitive deficits, neuronal damage and free radicals disorder induced by cerebral ischemia in rats. Biol. Pharm. Bull. 2006, 29, 805-810.
34. Xiong, Z.; Liu, C.; Wang, F.; Li, C.; Wang, W.; Wang, J.; Chen, J. Protective effects of breviscapine on ischemic vascular dementia in rats. Biol. Pharm. Bull. 2006, 29, 1880-1885.